Current CT and MRI possibilities to diagnose and differentiate dementia
Keywords:
dementia, computed tomography, magnetic resonance imaging, differential diagnosis of dementiaAbstract
All of the major neurodegenerative disorders have relatively specific imaging findings that can be identified. New MRI imaging techniques carry the hope of revolutionizing the diagnosis of neurodegenerative disease so as to obtain a complete molecular, structural, and metabolic characterization, which could be used to improve diagnosis and to stage each patient and follow disease progression and response to treatment. In this review we provide an overview of the various structural computed tomography (CT) and magnetic resonance imaging (MRI) methods used to image neurodegenerative disease and discuss their usefulness in specific neurodegenerative disorders.
References
1. Tartaglia M.C., Rosen H.J., Miller B.L. Neuroimaging in Dementia. Neurotherapeutics, 2011;8(1): 211-219.
2. Savoiardo M., Grisoli M. Imaging dementias. Eur. Radiol., 2001;11:484-492.
3. Knopman D.S., DeKosky S.T., Cummings J.L., Chui H., Corey-Bloom J., Relkin N., Small G.W., Miller B., Stevens J.C. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 2001; 8;56(9):1143-53.
4. Scheltens P. Early diagnosis of dementia: neuroimaging. J. Neurol., 1999; 246:16-20.
5. Bobinski M., Wegiel J., Wisniewski H.M., Tarnawski M., Bobinski M., Reisberg B., De Leon M.J., Miller D.C. Neurofibrillary pathology-correlation with hippocampal formation atrophy in Alzheimer’s disease. Neurobiol. Aging1996; 17:909-919.
6. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol., (Berl) 1991;82:239-259.
7. Appel J., Potter E., Shen Q., Pantol G., Greig M.T., Loewenstein D., Duara R. A comparative analysis of structural brain MRI in the diagnosis of Alzheimer’s disease. Behav. Neurol., 2009;21:13-19.
8. Jones B.F., Barnes J., Uylings H.B., Fox N.C., Frost C., Witter M.P., Scheltens P. Differential regional atrophy of the cingulate gyrus in Alzheimer disease: a volumetric MRI study. Cereb. Cortex, 2006;16:1701-1708.
9. Rusinek H., de Leon M.J., George A.E., Stylopoulos L.A., Chandra R., Smith G., Rand T., Mourino M., Kowalski H. Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology 1991;178:109-114.
10. De Leon M.J., George A.E., Stylopoulos L.A., Smith G., Miller D.C. Early marker for Alzheimer’s disease: the atrophic hippocampus. Lancet, 1989;2:672-673.
11. Jobst K.A., Smith A.D., Barker C.S. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry 1992, 55:190-194.
12. Kesslak J.P., Nalcioglu O., Cotman C.W. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer’s disease. Neurology, 1991, 41:51-54.
13. Killiany R.J., Moss M.B., Albert M.S., Sandor T., Tieman J., Jolesz F. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer’s disease. Arch. Neurol., 1993 50:949-954.
14. Pantel J., Schröder J., Schad L.R., Friedlinger M., Knopp M.V., Schmitt R., Geissler M., Blüml S., Essig M., Sauer H. Quantitative magnetic resonance imaging and neuropsychological functions in dementia of the Alzheimer type. Psychol. Med., 1997, 27:221-229.
15. Risacher S.L., Saykin A.J., West J.D., Shen L., Firpi H.A., McDonald B.C. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr. Alzheimer Res., 2009;6:347-361.
16. Du A.T., Schuff N., Zhu X.P., Jagust W.J., Miller B.L., Reed B.R., Kramer J.H., Mungas D., Yaffe K., Chui H.C., Weiner M.W. Atrophy rates of entorhinal cortex in AD and normal aging. Neurology, 2003;60:481-486.
17. Rosen H.J., Gorno-Tempini M.L., Goldman W.P. et al. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology, 2002;58:198-208.
18. Rosen H.J., Allison S.C., Schauer G.F., Gorno-Tempini M.L., Weiner M.W., Miller B.L. Neuroanatomical correlates of behavioural disorders in dementia. Brain, 2005;128:2612-2625.
19. Bonneville F., Bloch F., Kurys E., du Montcel S.T., Welter M.L., Bonnet A.M., Agid Y., Dormont D., Houeto J.L. Camptocormia and Parkinson's disease: MR imaging. Eur. Radiol. 2008;18(8):1710-1719.
20. Bloch F., Houeto J.L., Tezenas du Montcel S., Bonneville F., Etchepare F., Welter M.L., Rivaud-Pechoux S., Hahn-Barma V., Maisonobe T., Behar C., Lazennec J.Y., Kurys E., Arnulf I., Bonnet A.M., Agid Y. Parkinson's disease with camptocormia. J. Neurol. Neurosurg. Psychiatry, 2006;77(11):1223-1228.
21. Boxer A.L., Geschwind M.D., Belfor N. Gorno-Tempini M.L., Schauer G.F., Miller B.L., Weiner M.W., Rosen H.J. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch. Neurol., 2006;63: 81-86.
22. Seppi K., Schocke M.F. An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism. Curr. Opin. Neurol., 2005;18:370-375.
23. Kerchner G.A., Hess, C.P., Hammond-Rosenbluth K.E., Xu D., Rabinovici G.D., Kelley D.A., Vigneron D.B., Nelson S.J., Miller B.L. Hippocampal CA1 apical neuropil atrophy in mild Alzheimer disease visualized with 7-T MRI. Neurology, 2010;75:1381-1387.
24. Scheff SW, Price DA, Schmitt F.A., DeKosky S.T., Mufson E.J. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology, 2007;68:1501-1508.
25. Mizutani T, Kasahara M. Hippocampal atrophy secondary to entorhinal cortical degeneration in Alzheimer-type dementia. Neurosci. Lett., 1997;222:119-122.
26. Firbank M.J., Blamire A.M., Krishnan M.S., Teodorczuk A., English P., Gholkar A., Harrison R.M., O'Brien J.T. Diffusion tensor imaging in dementia with Lewy bodies and Alzheimer’s disease. Psychiatry Res., 2007;155:135-145.
27. Zhang Y., Schuff N., Du A.T., Rosen H.J., Kramer J.H., Gorno-Tempini M.L., Miller B.L., Weiner M.W. White matter damage in frontotemporal dementia and Alzheimer’s disease measured by diffusion MRI. Brain, 2009;132:2579-2592.
28. Roman G.C., Erkinjuntti T., Wallin A., Pantoni L., Chui H.C. Subcortical ischaemic vascular dementia. Lancet Neurol., 2002;1:426-436.
29. Young G.S., Geschwind M.D., Fischbein N.J., Martindale J.L., Henry R.G., Liu S., Lu Y., Wong S., Liu H., Miller B.L., Dillon W.P. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am. J. Neuroradiol., 2005;26:1551-1562.
30. Jellison B.J., Field A.S., Medow J., Lazar M., Salamat M.S., Alexander A.L. Diffusion tensor imaging of cerebral white matter: a pictorial review of physics, fiber tract anatomy, and tumor imaging patterns. AJNR Am. J. Neuroradiol., 2004;25:356-369.
31. Schuff N., Capizzano A.A., Du A.T., Amend D.L., O'Neill J., Norman D., Kramer J., Jagust W., Miller B., Wolkowitz O.M., Yaffe K., Weiner M.W. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology, 2002;58:928-935.
32. Schuff N., Capizzano A.A., Du A.T., Amend D.L., O'Neill J., Norman D., Jagust W.J., Chui H.C., Kramer J.H., Reed B.R., Miller B.L., Yaffe K., Weiner M.W. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD. Neurology, 2003;61:358-364.
33. Zimny A., Sasiadek M., Leszek J., Czarnecka A., Trypka E., Kiejna A. Does perfusion CT enable differentiating Alzheimer's disease from vascular dementia and mixed dementia? A preliminary report. J. Neurol Sci., 2007; 257:114-120.
Downloads
Published
Issue
Section
License
Copyright (c) 2011 Authors

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.